2017
DOI: 10.1002/em.22081
|View full text |Cite
|
Sign up to set email alerts
|

Use of genetic toxicity data in GHS mutagenicity classification and labeling of substances

Abstract: One of the key outcomes of testing the potential genotoxicity or mutagenicity of a substance is the conclusion on whether the substance should be classified as a germ cell mutagen and the significance of this for other endpoints such as carcinogenicity. The basis for this conclusion are the criteria presented in classification and labelling systems such as the Globally Harmonized System for classification and labeling (GHS). This article reviews the classification criteria for germ cell mutagenicity and carcin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…This includes stronger planning and scoping efforts to be incorporated early and regularly in the assessment process, and moving applied genotoxicity testing away from the yes/no testing paradigm and toward a risk assessment approach, including the quantitation of risk of adverse health outcomes, both cancer and noncancer, that can result from genetic damage. The commentary by Ball and Hollnagel briefly reviews the development of and revisions to the Globally Harmonized System (GHS) for Classification and Labeling of chemicals with a focus on the applicability of the GHS assessments, particularly the relevance to genotoxicity to an apical change (i.e., adverse effect) [Ball and Hollnagel, ]. The authors suggest some alternative means of hazard communication and characterization in an effort to provide an inclusive, risk‐based evaluation.…”
mentioning
confidence: 99%
“…This includes stronger planning and scoping efforts to be incorporated early and regularly in the assessment process, and moving applied genotoxicity testing away from the yes/no testing paradigm and toward a risk assessment approach, including the quantitation of risk of adverse health outcomes, both cancer and noncancer, that can result from genetic damage. The commentary by Ball and Hollnagel briefly reviews the development of and revisions to the Globally Harmonized System (GHS) for Classification and Labeling of chemicals with a focus on the applicability of the GHS assessments, particularly the relevance to genotoxicity to an apical change (i.e., adverse effect) [Ball and Hollnagel, ]. The authors suggest some alternative means of hazard communication and characterization in an effort to provide an inclusive, risk‐based evaluation.…”
mentioning
confidence: 99%